Sort

Search

01/09/2021 Molecular mapping of platelet hyperreactivity in diabetes: the stress proteins complex HSPA8/Hsp90/CSK2 alpha and platelet aggregation in diabetic and normal platelets
Chiva-Blanch, G, Pena, E, Cubedo, J, Garcia-Arguinzonis, M, Pane, A, Gil, PA, Perez, A, Ortega, E, Padro, T, Badimon, L. Molecular mapping of platelet hyperreactivity in diabetes: the stress proteins complex HSPA8/Hsp90/CSK2 alpha and platelet aggregation in diabetic and normal platelets. Translational Research. 2021; 235DOI:10.1016/j.trsl.2021.04.003. PMID:33887528. IF:10.171(Q1/1D).
01/09/2021 Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer
Granado-Casas, M, Martinez-Gonzalez, D, Martinez-Alonso, M, Doria, M, Alcubierre, N, Valls, J, Julve, J, Verdu-Soriano, J, Mauricio, D. Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer. Journal of Clinical Medicine. 2021; 10(17)DOI:10.3390/jcm10174023. PMID:34501471. IF:4.964(Q2/4D).
01/09/2021 Performance of early pregnancy HbA(1c) for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women (vol 168, 108378, 2020)
Immanuel, J, Simmons, D, Desoye, G, Corcoy, R, Adelantado, JM, Devlieger, R, Lapolla, A, Dalfra, MG, Bertolotto, A, Harreiter, J, Wender-Ozegowska, E, Zawiejska, A, Dunne, FP, Damm, P, Mathiesen, ER, Jensen, DM, Andersen, LLT, Hill, DJ, Jelsma, JGM, Snoek, FJ, Scharnagl, H, Galjaard, S, Kautzky-Willer, A, Van Poppel, MNM. Performance of early pregnancy HbA(1c) for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women (vol 168, 108378, 2020). DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 179DOI:10.1016/j.diabres.2021.109023. PMID:34479741. IF:8.180(Q1/2D).
01/09/2021 Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population
Oyaguez, I, Gomez-Peralta, F, Artola, S, Carrasco, FJ, Carretero-Gomez, J, Garcia-Soidan, J, Gomez-Huelgas, R, Merino-Torres, JF, Perez, A. Cost Analysis of FreeStyle Libre(R) 2 System in Type 2 Diabetes Mellitus Population. Diabetes Therapy. 2021; 12(9)DOI:10.1007/s13300-021-01064-4. PMID:33948909. IF:3.605(Q3/7D).
01/09/2021 ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
Luger, A, Broersen, LHA, Biermasz, NR, Biller, BMK, Buchfelder, M, Chanson, P, Jorgensen, JOL, Kelestimur, F, Llahana, S, Maiter, D, Mintziori, G, Petraglia, F, Verkauskiene, R, Webb, SM, Dekkers, OM. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2021; 185(3)DOI:10.1530/EJE-21-0462. PMID:34425558. IF:6.558(Q1/2D).
01/09/2021 Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain
Iglesias, P, Nocete, I, Rodriguez, MDM, Venegas-Moreno, E, Ares, J, Biagetti, B, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Villar-Taibo, R, Cordido, F, Paja, M, Glerean, M, Rivera, NG, Fuentes, ED, Blanco, C, Alvarez-Escola, C, Martin, T, Webb, SM, Bernabeu, I, Villabona, C, Soto-Moreno, A, Gaztambide, S, Diez, JJ. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain. NEUROENDOCRINOLOGY. 2021; 111(10)DOI:10.1159/000512161. PMID:33040060. IF:5.135(Q2/4D).
01/09/2021 Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Villanueva, C, Albillos, A, Genesca, J, Garcia-Pagan, JC, Brujats, A, Calleja, JL, Aracil, C, Banares, R, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Torres, F, Bosch, J. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. JOURNAL OF HEPATOLOGY. 2021; 75(3)DOI:10.1016/j.jhep.2021.04.022. PMID:33905794. IF:30.083(Q1/1D).
01/09/2021 Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Ampuero, J, Aller, R, Gallego-Duran, R, Crespo, J, Abad, J, Gonzalez-Rodriguez, A, Gomez-Camarero, J, Caballeria, J, Lo Iacono, O, Ibanez, L, Garcia-Samaniego, J, Martin-Mateos, R, Frances, R, Fernandez-Rodriguez, C, Diago, M, Soriano, G, Andrade, RJ, Latorre, R, Jorquera, F, Morillas, RM, Escudero, D, Estevez, P, Hernandez-Guerra, M, Augustin, S, Pareja-Megia, MJ, Banales, JM, Aspichueta, P, Benlloch, S, Rosales, JM, Salmeron, J, Turnes, J, Romero-Gomez, M. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. LIVER INTERNATIONAL. 2021; 41(9)DOI:10.1111/liv.14898. PMID:33896100. IF:8.754(Q1/2D).
01/09/2021 Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study
Murillo-Saich, JD, Diaz-Torne, C, Ortiz, MA, Coras, R, Gil-Alabarse, P, Pedersen, A, Corominas, H, Vidal, S, Guma, M. Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study. Metabolomics. 2021; 17(9)DOI:10.1007/s11306-021-01822-2. PMID:34402961. IF:4.747(Q2/4D).
01/09/2021 Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
de-Torres, JP, O'Donnell, DE, Marin, JM, Cabrera, C, Casanova, C, Marin, M, Ezponda, A, Cosio, BG, Martinez, C, Solanes, I, Fuster, A, Neder, JA, Gonzalez-Gutierrez, J, Celli, BR. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD. CHEST. 2021; 160(3)DOI:10.1016/j.chest.2021.04.033. PMID:33901498. IF:11.393(Q1/1D).
01/09/2021 Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Gonzalez-Cordon, A, Assoumou, L, Moyle, G, Waters, L, Johnson, M, Domingo, P, Fox, J, Stellbrink, HJ, Guaraldi, G, Masia, M, Gompels, M, De Wit, S, Florence, E, Esser, S, Raffi, F, Behrens, G, Pozniak, A, Gatell, JM, Martinez, E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9)DOI:10.1093/jac/dkab158. PMID:34120186. IF:5.758(Q1/2D).
01/09/2021 Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
Blackhall, F, Jao, K, Greillier, L, Cho, BC, Penkov, K, Reguart, N, Majem, M, Nackaerts, K, Syrigos, K, Hansen, K, Schuette, W, Cetnar, J, Cappuzzo, F, Okamoto, I, Erman, M, Langer, SW, Kato, T, Groen, H, Sun, ZW, Luo, Y, Tanwani, P, Caffrey, L, Komarnitsky, P, Reinmuth, N. Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study. Journal of Thoracic Oncology. 2021; 16(9)DOI:10.1016/j.jtho.2021.02.009. PMID:33607312. IF:20.121(Q1/1D).
01/09/2021 LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Garrido, P, Paz-Ares, L, Majem, M, Moran, T, Trigo, JM, Bosch-Barrera, J, Garcia-Campelo, R, Gonzalez-Larriba, JL, Sanchez-Torres, JM, Isla, D, Vinolas, N, Camps, C, Insa, A, Juan, O, Massuti, B, Paredes, A, Artal, A, Lopez-Brea, M, Palacios, J, Felip, E. LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology. Cancer Medicine. 2021; 10(17)DOI:10.1002/cam4.4135. PMID:34296539. IF:4.711(Q2/5D).
01/09/2021 Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe
Vokinger, KN, Hwang, TJ, Daniore, P, Lee, CC, Tibau, A, Grischott, T, Rosemann, TJ, Kesselheim, AS. Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe. JAMA Oncology. 2021; 7(9)DOI:10.1001/jamaoncol.2021.2026. PMID:34196656. IF:33.012(Q1/1D).
01/09/2021 Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors
Moreno, V, Greil, R, Yachnin, J, Majem, M, Wermke, M, Arkenau, HT, Basque, JR, Nidamarthy, PK, Kapoor, S, Cui, XM, Giovannini, M. Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors. CLINICAL THERAPEUTICS. 2021; 43(6)DOI:10.1016/j.clinthera.2021.04.006. PMID:34053700. IF:3.637(Q2/5D).
01/09/2021 Risk of contagion of SARS-CoV-2 among otorhinolaryngologists in Spain during the "Two waves"
Martin-Villares, C, Bernal-Sprekelsen, M, Molina-Ramirez, CP, Bartolome-Benito, M, Orus, C, Escamilla Carpintero, Yolanda. Risk of contagion of SARS-CoV-2 among otorhinolaryngologists in Spain during the "Two waves". EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2021; 278(9)DOI:10.1007/s00405-020-06582-8. PMID:33464400. IF:3.236(Q2/3D).
01/09/2021 The EHA Research Roadmap: Malignant Myeloid Diseases
Dohner, H, Malcovati, L, Ossenkoppele, GJ, Hochhaus, A, Vannucchi, AM, Bullinger, L, Cervantes, F, Craddock, C, de Witte, T, Dohner, K, Dombret, H, Fenaux, P, Geissler, J, Germing, U, Guilhot, F, Harrison, C, Hellstrom-Lindberg, E, Passamonti, F, Sierra, J, Skoda, R, Wierzbowska, A. The EHA Research Roadmap: Malignant Myeloid Diseases. Hemasphere. 2021; 5(9)DOI:10.1097/HS9.0000000000000635. PMID:34476345. IF:8.300(Q1/2D).
01/09/2021 Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
Larson, RA, Mandrekar, SJ, Huebner, LJ, Sanford, B, Laumann, K, Geyer, S, Bloomfield, CD, Thiede, C, Prior, TW, Dohner, K, Marcucci, G, Voso, MT, Klisovic, RB, Galinsky, I, Wei, AH, Sierra, J, Sanz, MA, Brandwein, JM, de Witte, T, Niederwieser, D, Appelbaum, FR, Medeiros, BC, Tallman, MS, Krauter, J, Schlenk, RF, Ganser, A, Serve, H, Ehninger, G, Amadori, S, Gathmann, I, Dohner, H, Stone, RM. Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial. LEUKEMIA. 2021; 35(9)DOI:10.1038/s41375-021-01179-4. PMID:33654204. IF:12.897(Q1/1D).
01/09/2021 European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines
Steiner, T, Dichgans, M, Norrving, B, Aamodt, AH, Berge, E, Christensen, H, Fuentes, B, Khatri, P, Korompoki, E, Marti-Fabregas, J, Quinn, T, Toni, D, Zedde, M, Sacco, S, Turc, G. European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines. European Stroke Journal. 2021; 6(3)DOI:10.1177/23969873211024143. PMID:34746429. IF:5.894(Q1/2D).
01/09/2021 Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia
Ramos-Pachon, A, Garcia-Tornel, A, Millan, M, Ribo, M, Amaro, S, Cardona, P, Marti-Fabregas, J, Roquer, J, Silva, Y, Ustrell, X, Purroy, F, Gomez-Choco, M, Zaragoza-Brunet, J, Canovas, D, Krupinski, J, Sala, NM, Palomeras, E, Cocho, D, Redondo, L, Repullo, C, Sanjurjo, E, Carrion, D, Lopez, M, Almendros, MC, Barcelo, M, Monedero, J, Catena, E, Rybyeba, M, Diaz, G, Jimenez-Fabrega, X, Sola, S, Hidalgo, V, Pueyo, MJ, de la Ossa, NP, Urra, X. Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia. CEREBROVASCULAR DISEASES. 2021; 50(5)DOI:10.1159/000516309. PMID:34023822. IF:3.104(Q3/6D).